Cargando…

Longitudinal trajectories in negative symptoms and changes in brain cortical thickness: 10-year follow-up study

BACKGROUND: Understanding the evolution of negative symptoms in first-episode psychosis (FEP) requires long-term longitudinal study designs that capture the progression of this condition and the associated brain changes. AIMS: To explore the factors underlying negative symptoms and their association...

Descripción completa

Detalles Bibliográficos
Autores principales:	Canal-Rivero, Manuel, Ruiz-Veguilla, Miguel, Ortiz-García de la Foz, Victor, López-Díaz, Alvaro, Garrido-Torres, Nathalia, Ayesa-Arriola, Rosa, Vazquez-Bourgon, Javier, Mayoral-van Son, Jacqueline, Brambilla, Paolo, Kircher, Tilo, Romero-García, Rafael, Crespo-Facorro, Benedicto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2023
Materias:	Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331319/ https://www.ncbi.nlm.nih.gov/pubmed/36805840 http://dx.doi.org/10.1192/bjp.2022.192

Ejemplares similares

S101. DIFFERENTIATING NON-AFFECTIVE ACUTE REMITTING PSYCHOSIS (NARP) FROM SCHIZOPHRENIA IN FIRST-EPISODE PSYCHOSIS: FINDINGS FROM A 3-YEAR LONGITUDINAL STUDY IN THE PAFIP COHORT
por: López-Díaz, Álvaro, et al.
Publicado: (2020)

M97. PREDICTORS OF TRANSITION TO SCHIZOPHRENIA IN BRIEF PSYCHOTIC DISORDER: FINDINGS FROM A 3-YEAR LONGITUDINAL STUDY IN THE PAFIP COHORT
por: López-Díaz, Álvaro, et al.
Publicado: (2020)

Aripiprazole vs Risperidone Head-to-Head Effectiveness in First-Episode Non-Affective-Psychosis: A 3-Month Randomized, Flexible-Dose, Open-Label Clinical Trial
por: Garrido-Sánchez, Lucía, et al.
Publicado: (2022)

COVID-19 Infection During Pregnancy and Risk of Neurodevelopmental Disorders in Offspring: Time for Collaborative Research
por: López-Díaz, Álvaro, et al.
Publicado: (2021)

T175. A 10-YEAR LONGITUDINAL STUDY OF GREY MATTER VOLUME IN FIRST EPISODE OF NON-AFFECTIVE PSYCHOSIS
por: Tordesillas-Gutiérrez, Diana, et al.
Publicado: (2018)

Treatment Discontinuation Impact on Long-Term (10-Year) Weight Gain and Lipid Metabolism in First-Episode Psychosis: Results From the PAFIP-10 Cohort
por: Vázquez-Bourgon, Javier, et al.
Publicado: (2020)

Aripiprazole and Risperidone Present Comparable Long-Term Metabolic Profiles: Data From a Pragmatic Randomized Controlled Trial in Drug-Naïve First-Episode Psychosis
por: Vázquez-Bourgon, Javier, et al.
Publicado: (2022)

Expression and Functionality Study of 9 Toll-Like Receptors in 33 Drug-Naïve Non-Affective First Episode Psychosis Individuals: A 3-Month Study
por: Juncal-Ruiz, Maria, et al.
Publicado: (2020)

The impact of COVID-19 pandemic on the psychological well-being among health care workers: A 6-month cohort longitudinal survey study
por: Canal-Rivero, Manuel, et al.
Publicado: (2023)

COVID-19 una oportunidad única para explorar la relación entre la infección prenatal materna, el desarrollo cerebral y los trastornos neuropsiquiátricos en la descendencia
por: Ayesa-Arriola, Rosa, et al.
Publicado: (2021)

COVID-19 una oportunidad única para explorar la relación entre la infección prenatal materna, el desarrollo cerebral y los trastornos neuropsiquiátricos en la descendencia
por: Ayesa-Arriola, Rosa, et al.
Publicado: (2021)

Data regarding active psychosis and functional outcome, among other clinical variables, during early phases of the illness in first-episode psychosis in the PAFIP 10-year follow-up program
por: Pardo-de-Santayana, Guillermo, et al.
Publicado: (2020)

S124. RECOVERY TRAJECTORIES IN FIRST EPISODE PSYCHOSIS PATIENTS: THE ROLE OF TIMING
por: Ayesa-Arriola, Rosa, et al.
Publicado: (2018)

S173. GREY MATTER VOLUME DEFFICITS IN PATIENTS WITH A FIRST EPISODE NON-AFFECTIVE PSYCHOSIS AND SUICIDE RELATED BEHAVIOUR
por: Tordesillas-Gutiérrez, Diana, et al.
Publicado: (2018)

Understanding sex differences in long-term outcomes after a first episode of psychosis
por: Ayesa-Arriola, Rosa, et al.
Publicado: (2020)

Trauma and stressor-related disorders among health care workers during COVID-19 pandemic and the role of the gender: A prospective longitudinal survey.
por: Canal-Rivero, Manuel, et al.
Publicado: (2022)

Data regarding the effect of cannabis consumption on liver function in the prospective PAFIP cohort of first episode psychosis
por: Vázquez-Bourgon, Javier, et al.
Publicado: (2019)

Pattern of long-term weight and metabolic changes after a first episode of psychosis: Results from a 10-year prospective follow-up of the PAFIP program for early intervention in psychosis cohort
por: Vázquez-Bourgon, J., et al.
Publicado: (2022)

Understanding the Influence of Personality Traits on Risk of Suicidal Behaviour in Schizophrenia Spectrum Disorders: A Systematic Review
por: Canal-Rivero, Manuel, et al.
Publicado: (2021)

Aripiprazole as a Candidate Treatment of COVID-19 Identified Through Genomic Analysis
por: Crespo-Facorro, Benedicto, et al.
Publicado: (2021)

T72. VERBAL MEMORY AND VOXEL BASED MORPHOMETRY IN FIRST EPISODE NON-AFFECTIVE PSYCHOSIS: A PROCESS ORIENTED APPROACH
por: Ayesa-Arriola, Rosa, et al.
Publicado: (2018)

F81. AGE OF ONSET OF CANNABIS USE AND COGNITIVE FUNCTION IN FIRST EPISODE NON-AFFECTIVE PSYCHOSIS PATIENTS: 3-YEAR FOLLOW-UP OUTCOME
por: Setién-Suero, Esther, et al.
Publicado: (2018)

F124. SEX DIFFERENCES IN OUTCOME IN FIRST EPISODE PSYCHOSIS PATIENTS: A 10-YEAR FOLLOW-UP STUDY
por: Ayesa-Arriola, Rosa, et al.
Publicado: (2018)

Epidemiology of infection, transmission and COVID-19 outcomes among mental health users and workers in a comprehensive network of long-term mental health facilities: Retrospective observational population-base study
por: Canal-Rivero, Manuel, et al.
Publicado: (2023)

Lower risk of SARS-CoV2 infection in individuals with severe mental disorders on antipsychotic treatment: A retrospective epidemiological study in a representative Spanish population
por: Canal-Rivero, M., et al.
Publicado: (2021)

The role of antipsychotics against COVID-19: A topic for debate
por: Canal-Rivero, M., et al.
Publicado: (2021)

S125. THE DYNAMIC RELATIONSHIP BETWEEN INSIGHT AND SUICIDAL BEHAVIOUR IN FIRST EPISODE PSYCHOSIS PATIENTS OVER 3-YEAR FOLLOW-UP
por: Ayesa-Arriola, Rosa, et al.
Publicado: (2018)

A Disrupted-in-Schizophrenia 1 Gene Variant is Associated with Clinical Symptomatology in Patients with First-Episode Psychosis
por: Vázquez-Bourgon, Javier, et al.
Publicado: (2014)

F101. CANNABIS USE AND HEPATIC STEATOSIS IN PSYCHOSIS: RESULTS FROM A 3-YEAR LONGITUDINAL STUDY
por: Vázquez-Bourgon, Javier, et al.
Publicado: (2018)

Neuroanatomical Differences between First-Episode Psychosis Patients with and without Neurocognitive Deficit: A 3-Year Longitudinal Study
por: Ayesa-Arriola, Rosa, et al.
Publicado: (2013)

Childhood trauma and substance use underlying psychosis: a systematic review
por: Setién-Suero, Esther, et al.
Publicado: (2020)

Antipsychotic Treatment Effectiveness in First Episode of Psychosis: PAFIP 3-Year Follow-Up Randomized Clinical Trials Comparing Haloperidol, Olanzapine, Risperidone, Aripiprazole, Quetiapine, and Ziprasidone
por: Gómez-Revuelta, Marcos, et al.
Publicado: (2020)

Long-Term Antipsychotic Effectiveness in First Episode of Psychosis: A 3-Year Follow-Up Randomized Clinical Trial Comparing Aripiprazole, Quetiapine, and Ziprasidone
por: Gómez-Revuelta, Marcos, et al.
Publicado: (2018)

Disentangling early and late onset of psychosis in women
por: Díaz-Pons, A., et al.
Publicado: (2022)

Short-term emotional impact of COVID-19 pandemic on Spaniard health workers
por: Rodriguez-Menéndez, Gonzalo, et al.
Publicado: (2021)

Intelligence Quotient changes over 10 years: diversity of cognitive profiles in first episode of psychosis and healthy controls
por: Murillo-Garcia, N., et al.
Publicado: (2023)

Current Data on and Clinical Insights into the Treatment of First Episode Nonaffective Psychosis: A Comprehensive Review
por: Crespo-Facorro, Benedicto, et al.
Publicado: (2016)

Counterfactual Reasoning in Non-psychotic First-Degree Relatives of People with Schizophrenia
por: Albacete, Auria, et al.
Publicado: (2016)

Cannabis use in male and female first episode of non-affective psychosis patients: Long-term clinical, neuropsychological and functional differences
por: Setién-Suero, Esther, et al.
Publicado: (2017)

The psychosis metabolic risk calculator (PsyMetRiC) for young people with psychosis: International external validation and site-specific recalibration in two independent European samples
por: Perry, Benjamin I., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_innpo9kjg7bgths9bkrredn9ep